Learn about the evidenceKnee + hip
No proof these injections restore worn cartilage.
WHO MAY BENEFITUnderstanding claims about marrow concentrate, stem cells, and microfragmented fat.
THE EVIDENCEPossible symptom benefit; low certainty
Understand this option ↗Costs, coverage & FDA status
Illustrative cash: No treatment offered here
Medicare: Generally not covered
No routine OA coverage.
FDA status: Not approved for osteoarthritis
FDA states that regenerative medicine therapies have not been approved for orthopedic conditions such as osteoarthritis. Processing-device clearance or use of your own marrow or fat is not approval of a joint-repair claim. Regulatory requirements depend on the exact product and processing.
Site summary of FDA information · reviewed September 19, 2026. Refer to current product labeling. This is not an FDA endorsement of this site.Learn about the evidenceKnee + hip
Unapproved joint injections. No buy button.
WHO MAY BENEFITUnderstanding amniotic, umbilical, Wharton’s jelly, and exosome claims.
THE EVIDENCEInvestigational evidence; no class-wide efficacy conclusion
Understand this option ↗Costs, coverage & FDA status
Illustrative cash: No treatment offered here
Medicare: Generally not covered
No routine OA coverage.
FDA status: Not approved for OA injections
Not approved for OA injection; FDA warns patients about unapproved regenerative products.
Site summary of FDA information · reviewed September 19, 2026. Refer to current product labeling. This is not an FDA endorsement of this site.Learn about the evidenceKnee + hip
You may hear about them. We do not offer them.
WHO MAY BENEFITChecking a proposed injection before spending money.
THE EVIDENCENot established as routine OA care
Understand this option ↗Costs, coverage & FDA status
Illustrative cash: No treatment offered here
Medicare: Generally not covered
No routine OA coverage.
FDA status: No OA approval established here
This catalog does not establish an FDA-approved osteoarthritis indication for prolotherapy, ozone, or joint Botox. An approved ingredient or drug for another use does not establish approval of an OA injection. Confirm the exact substance, formulation, and route.
Site summary of FDA information · reviewed September 19, 2026. Refer to current product labeling. This is not an FDA endorsement of this site.Learn about the evidenceKnee + hip
A watch-list item. No US checkout here.
WHO MAY BENEFITUnderstanding a polyacrylamide hydrogel offered elsewhere.
THE EVIDENCEActive-comparator evidence; placebo benefit uncertain
Understand this option ↗Costs, coverage & FDA status
Illustrative cash: No treatment offered here
Medicare: Generally not covered
No established coverage in this catalog.
FDA status: US approval: UNSURE
US approval has not been established in this catalog. No US SKU is offered.
Site summary of FDA information · reviewed September 19, 2026. Refer to current product labeling. This is not an FDA endorsement of this site.Learn about the evidenceknee
An artery procedure, not a joint injection.
WHO MAY BENEFITA specialist discussion of an emerging knee procedure.
THE EVIDENCEPromising procedure; recommendations differ
Understand this option ↗Costs, coverage & FDA status
Illustrative cash: No treatment offered here
Medicare: Coverage may apply; individual criteria must be checked.
UNSURE; policy and case-specific review required. No booking is available here.
FDA status: Embolic product and use must be checked
FDA regulates the embolic materials used in GAE. The cited Embosphere clearance lists tumors, uterine fibroids, prostatic arteries for BPH, and arteriovenous malformations; it does not list knee osteoarthritis. That record must not be presented as an FDA-cleared knee OA indication. Confirm the exact material and current labeling with the interventional radiologist.
Site summary of FDA information · reviewed September 19, 2026. Refer to current product labeling. This is not an FDA endorsement of this site.Learn about the evidenceKnee + hip
Mixed evidence. Exercise still matters.
WHO MAY BENEFITUnderstanding photobiomodulation (light treatment) claims.
THE EVIDENCEPossible symptom benefit; protocol-dependent
Understand this option ↗Costs, coverage & FDA status
Illustrative cash: No treatment offered here
Medicare: Generally not covered
Home light gadgets are generally cash purchases.
FDA status: Exact device and claim must be checked
Some devices are cleared for specific pain uses. This is not an OA drug approval.
Site summary of FDA information · reviewed September 19, 2026. Refer to current product labeling. This is not an FDA endorsement of this site.Learn about the evidenceKnee + hip
Popular supplements. Not new cartilage.
WHO MAY BENEFITAn evidence check before buying a supplement.
THE EVIDENCEInconsistent benefit; not routine OA care
Understand this option ↗Costs, coverage & FDA status
Illustrative cash: No treatment offered here
Medicare: Generally not covered
Supplements are not covered OA drugs.
FDA status: Supplements · no disease-treatment approval
Supplements are not FDA-approved OA drugs.
Site summary of FDA information · reviewed September 19, 2026. Refer to current product labeling. This is not an FDA endorsement of this site.Learn about the evidenceKnee + hip
Possible symptom relief. No treatment promise.
WHO MAY BENEFITDiscussing supplements you already take with a clinician.
THE EVIDENCEPossible modest benefit; formulation-specific
Understand this option ↗Costs, coverage & FDA status
Illustrative cash: No treatment offered here
Medicare: Generally not covered
No supplement coverage as OA treatment.
FDA status: Supplements · no disease-treatment approval
Dietary supplements, not approved OA drugs.
Site summary of FDA information · reviewed September 19, 2026. Refer to current product labeling. This is not an FDA endorsement of this site.Learn about the evidenceKnee + hip
No antioxidant protocol. No house brand.
WHO MAY BENEFITReviewing collagen, MSM, fish oil, vitamin D, or antioxidant claims.
THE EVIDENCEMixed evidence by ingredient
Understand this option ↗Costs, coverage & FDA status
Illustrative cash: No treatment offered here
Medicare: Generally not covered
No routine OA supplement coverage.
FDA status: Supplements · no disease-treatment approval
Supplements are not FDA-approved disease treatments.
Site summary of FDA information · reviewed September 19, 2026. Refer to current product labeling. This is not an FDA endorsement of this site.Learn about the evidenceKnee + hip
Not another rung. Not an alternative to replacement.
WHO MAY BENEFITUnderstanding BPC-157, TB-500, KPV, MOTS-c, GHK-Cu, and “Wolverine stack” claims.
THE EVIDENCEPredominantly preclinical evidence
Understand this option ↗Costs, coverage & FDA status
Illustrative cash: No treatment offered here
Medicare: Generally not covered
No OA coverage.
FDA status: Not approved for OA or joint recovery
BPC-157, TB-500, KPV, MOTS-c, and injectable GHK-Cu are not FDA-approved treatments for osteoarthritis or joint-replacement recovery. FDA identifies safety uncertainties for these compounding substances. A committee discussion, pharmacy license, or compounded formulation is not FDA drug approval.
Site summary of FDA information · reviewed September 19, 2026. Refer to current product labeling. This is not an FDA endorsement of this site.Learn about the evidenceKnee + hip
Medicare may pay. That does not make this good care.
WHO MAY BENEFITDiscussing an existing prescription safely with your clinician.
THE EVIDENCENot a routine long-term OA pathway
Understand this option ↗Costs, coverage & FDA status
Illustrative cash: No treatment offered here
Medicare: Coverage may apply; individual criteria must be checked.
Prescription coverage may apply. Payment is not an evidence endorsement.
FDA status: Approved drugs · label-specific use
Approved pain medicines exist; approval is not a recommendation for routine OA treatment.
Site summary of FDA information · reviewed September 19, 2026. Refer to current product labeling. This is not an FDA endorsement of this site.Learn about the evidenceknee
Not recommended as a knee OA treatment.
WHO MAY BENEFITChecking claims about unloading shoe inserts.
THE EVIDENCENot recommended as routine knee OA treatment
Understand this option ↗Costs, coverage & FDA status
Illustrative cash: No treatment offered here
Medicare: Generally not covered
Not offered as covered OA treatment here.
FDA status: Exact product not verified
A device’s regulatory status is not a clinical recommendation.
Site summary of FDA information · reviewed September 19, 2026. Refer to current product labeling. This is not an FDA endorsement of this site.
